Major Madhukar

ORCID: 0000-0003-3609-9797
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • SARS-CoV-2 and COVID-19 Research
  • Research on Leishmaniasis Studies
  • Mosquito-borne diseases and control
  • Trypanosoma species research and implications
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 detection and testing
  • COVID-19 epidemiological studies
  • Tuberculosis Research and Epidemiology
  • Myasthenia Gravis and Thymoma
  • Eosinophilic Disorders and Syndromes
  • Infectious Encephalopathies and Encephalitis
  • Pneumonia and Respiratory Infections
  • Viral Infections and Vectors
  • Digital Imaging for Blood Diseases
  • Diagnosis and treatment of tuberculosis
  • Rabies epidemiology and control
  • Animal Virus Infections Studies
  • Streptococcal Infections and Treatments
  • Virology and Viral Diseases
  • Cholesterol and Lipid Metabolism
  • vaccines and immunoinformatics approaches
  • Chronic Disease Management Strategies
  • Herpesvirus Infections and Treatments
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Mycobacterium research and diagnosis

Rajendra Memorial Research Institute of Medical Sciences
2018-2025

Indian Council of Medical Research
2023

All India Institute of Medical Sciences
2018

National Institute of Cholera and Enteric Diseases
2018

Swami Ramanand Teerth Marathwada University
2012

Little Flower Hospital & Research Centre
2006

Manoj Murhekar Tarun Bhatnagar Sriram Selvaraju V. Saravanakumar Jeromie Wesley Vivian Thangaraj and 95 more Naman K. Shah Muthusamy Santhosh Kumar Kiran Rade R. Sabarinathan Smita Asthana Rakesh Balachandar Sampada Dipak Bangar Avi Kumar Bansal Jyothi Bhat Vishal Chopra Dasarathi Das Alok Kumar Deb Kangjam Rekha Devi Gaurav Raj Dwivedi Muhammad Salim Khan C. P. Girish Kumar M. Sunil Kumar Avula Laxmaiah Major Madhukar Amarendra Mahapatra Suman Sundar Mohanty Chethana Rangaraju Alka Turuk Dinesh Kumar Baradwaj Ashrafjit S. Chahal Falguni Debnath Inaamul Haq Arshad Kalliath Srikanta Kanungo Jaya Singh Kshatri Gangeti Gandhi Jayanthi Naga Lakshmi Anindya Mitra A. Nirmala Ganta Venkata Prasad Mariya Amin Qurieshi Seema Sahay Ramesh Kumar Sangwan Krithikaa Sekar Vijay K. Shukla Prashant Kumar Singh Pushpendra Singh Rajeev Singh Dantuluri Sheethal Varma Ankit Viramgami Samiran Panda D. C. S. Reddy Balram Bhargava Rushikesh Andhalkar Anshuman Chaudhury Hirawati Deval Sarang Dhatrak Rajeev Ranjan Gupta Ezhilarasan Ilayaperumal Babu Jagjeevan Ramesh Chandra Jha K Kiran Nivethitha N. Krishnan Alok Kumar VG Vinoth Kumar K. Nagbhushanam Nimmathota Arlappa Ashok Kumar Pandey Harpreet Singh Pawar Kushal Singh Rathore Aby Robinson Hari Bhan Singh Vimith Cheruvathoor Wilson Ashwini Yadav Suresh Yadav T. Karunakaran Josephine Pradhan Tharsan Sivakumar Annamma Jose K Kalaiyarasi Sauvik Dasgupta R Anusha Tanu Anand Giridhara R. Babu Himanshu Chauhan Tanzin Dikid Raman Gangakhedkar Shashi Kant Sanket Kulkarni J. Muliyil Ravindra Mohan Pandey Swarup Sarkar Aakash Shrivastava Sujeet Kumar Singh Sanjay Zodpey Aparup Das Pradeep Das Shanta Dutta Rajni Kant Kanwar Narain Somashekar Narasimhaiah

BackgroundThe first national severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serosurvey in India, done May–June, 2020, among adults aged 18 years or older from 21 states, found a SARS-CoV-2 IgG antibody seroprevalence of 0·73% (95% CI 0·34–1·13). We aimed to assess the more recent nationwide general population India.MethodsWe did second household individuals 10 same 700 villages wards within 70 districts India that were included serosurvey. Individuals younger than and...

10.1016/s2214-109x(20)30544-1 article EN cc-by-nc-nd The Lancet Global Health 2021-01-27
Manoj Murhekar Tarun Bhatnagar Jeromie Wesley Vivian Thangaraj V. Saravanakumar Muthusamy Santhosh Kumar and 95 more Sriram Selvaraju Kiran Rade C. P. Girish Kumar R. Sabarinathan Alka Turuk Smita Asthana Rakesh Balachandar Sampada Dipak Bangar Avi Kumar Bansal Vishal Chopra Dasarathi Das Alok Kumar Deb Kangjam Rekha Devi Vikas Dhikav Gaurav Raj Dwivedi Muhammad Salim Khan M. Sunil Kumar Avula Laxmaiah Major Madhukar Amarendra Mahapatra Chethana Rangaraju Jyotirmayee Turuk Rajiv Yadav Rushikesh Andhalkar K. Arunraj Dinesh Kumar Bharadwaj Pravin Bharti Debdutta Bhattacharya Jyothi Bhat Ashrafjit S. Chahal Debjit Chakraborty Anshuman Chaudhury Hirawati Deval Sarang Dhatrak R. S. Dayal D. Elantamilan Prathiksha Giridharan Inaamul Haq Ramesh Kumar Hudda Babu Jagjeevan Arshad Kalliath Srikanta Kanungo Nivethitha N. Krishnan Jaya Singh Kshatri Alok Kumar Niraj Kumar Virendra Kumar Gangeti Gandhi Jayanthi Naga Lakshmi Ganesh Mehta Nandan Kumar Mishra Anindya Mitra K. Nagbhushanam Nimmathota Arlappa A. Nirmala Ashok Kumar Pandey Ganta Venkata Prasad Mariya Amin Qurieshi Sirasanambatti Devarajulu Reddy Aby Robinson Seema Sahay Rochak Saxena Krithikaa Sekar Vijay K. Shukla Hari Bhan Singh Prashant Kumar Singh Pushpendra Singh Rajeev Singh Nivetha Srinivasan Dantuluri Sheethal Varma Ankit Viramgami Vimith Cheruvathoor Wilson Surabhi Yadav Suresh Yadav Kamran Zaman Amit Chakrabarti Aparup Das Rupinder Singh Dhaliwal Shanta Dutta Rajni Kant Anam Khan Kanwar Narain Somashekar Narasimhaiah Chandrasekaran Padmapriyadarshini Krishna Pandey Sanghamitra Pati Shripad A. Patil Hemalatha Rajkumar Tekumalla Ramarao Y.K. Sharma Shalini Singh Samiran Panda D. C. S. Reddy Balram Bhargava Tanu Anand Giridhara R. Babu

BackgroundEarlier serosurveys in India revealed seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) 0.73% May–June 2020 and 7.1% August–September 2020. A third serosurvey was conducted between December January 2021 to estimate the SARS-CoV-2 infection among general population healthcare workers (HCWs) India.MethodsThe same 70 districts as first second serosurveys. For each district, at least 400 individuals aged ≥10 years from 100 HCWs subdistrict-level health...

10.1016/j.ijid.2021.05.040 article EN cc-by-nc-nd International Journal of Infectious Diseases 2021-05-19

Background India began COVID-19 vaccination in January 2021, initially targeting healthcare and frontline workers. The strategy was expanded a phased manner currently covers all individuals aged 18 years above. experienced severe second wave of during March–June 2021. We conducted fourth nationwide serosurvey to estimate prevalence SARS-CoV-2 antibodies the general population ≥6 workers (HCWs). Methods findings did cross-sectional study between 14 June 6 July 2021 same 70 districts across 20...

10.1371/journal.pmed.1003877 article EN cc-by PLoS Medicine 2021-12-10

The risk of tuberculosis (TB) disease is higher in individuals with TB infection. In a endemic country like India, it essential to understand the current burden infection at population level. objective present analysis estimate prevalence India and explore factors associated infection.Individuals aged > 15 years recently completed National survey who were tested for by QuantiFERON-TB Gold Plus (QFT-Plus) assay considered this sub-analysis. was defined as positive QFT-Plus (value >0.35...

10.1016/j.jiph.2023.10.009 article EN cc-by-nc-nd Journal of Infection and Public Health 2023-10-13

Rotavirus (RV) is a leading cause of severe gastroenteritis in infants and young children, often resulting dehydration hospitalization. Although global data on RV well-documented, there limited information its prevalence genetic diversity Bihar, India. This study aimed to investigate the infections patient, from January 2021 June 2024, assess associated molecular epidemiological patterns. In this retrospective conducted at Rajendra Memorial Research Institute Medical Sciences, Patna, 1,820...

10.4269/ajtmh.24-0543 article EN American Journal of Tropical Medicine and Hygiene 2025-02-25

Evidence on the implementation aspects of nutritional support interventions for persons with TB in India is limited. This qualitative study employed focus group discussions (n = 71), their family caregivers 17), and healthcare providers 18). The was conducted from August 2023 to April 2024 five states India. Participants’ knowledge, perceptions, practices about intake, experiences, expectations when accessing were explored. Four nutrition-related themes emerged: (a) experiences perceptions...

10.3390/tropicalmed10040114 article EN cc-by Tropical Medicine and Infectious Disease 2025-04-21

Background In Southeast Asia, treatment is recommended for all patients with post-kala-azar dermal leishmaniasis (PKDL). Adherence to the first-line regimen, twelve weeks of miltefosine (MF), low and ocular toxicity has been observed this exposure period. We assessed safety efficacy two shorter-course treatments: liposomal amphotericin B (LAmB) alone combined MF. Methodology/Principal findings An open-label, phase II, randomized, parallel-arm, non-comparative trial was conducted in...

10.1371/journal.pntd.0012242 article EN cc-by PLoS neglected tropical diseases 2024-06-20

Background: The first round of national serosurvey in India was conducted May-June 2020 among adults from 21 States. second August-September to estimate the nationwide seroprevalence for SARS-CoV-2 infection general population aged ten years and above. Methods: household individuals above same 700 villages wards 70 districts selected during serosurvey. Blood samples were tested using Abbott IgG assay. Seroprevalence estimated after applying sampling weights adjusting clustering assay...

10.2139/ssrn.3715460 article EN SSRN Electronic Journal 2020-01-01
Manoj Murhekar Tarun Bhatnagar Jeromie Wesley Vivian Thangaraj V. Saravanakumar Muthusamy Santhosh Kumar and 91 more Sriram Selvaraju Kiran Rade C. P. Girish Kumar R. Sabarinathan Alka Turuk Smita Asthana Rakesh Balachandar Sampada Dipak Bangar Avi Kumar Bansal Vishal Chopra Dasarathi Das Alok Kumar Deb Kangjam Rekha Devi Vikas Dhikav Gaurav Raj Dwivedi Muhammad Salim Khan M. Sunil Kumar Avula Laxmaiah Major Madhukar Amarendra Mahapatra Chethana Rangaraju Jyotirmayee Turuk Rushikesh Andhalkar K. Arunraj Dinesh Kumar Baradwaj Pravin Bharti Debdutta Bhattacharya Jyothi Bhat Ashrafjit S. Chahal Debjit Chakraborty Anshuman Chaudhury Hirawati Deval Sarang Dhatrak Ranjit Prasad D. Elantamilan Prathiksha Giridharan Inaamul Haq Ramesh Kumar Hudda Babu Jagjeevan Arshad Kalliath Srikanta Kanungo Nivethitha N. Krishnan Jaya Singh Kshatri Alok Kumar Niraj Kumar Vijay Kumar Gangeti Gandhi Jayanthi Naga Lakshmi Ganesh Mehta Nandan Kumar Mishra Anindya Mitra K. Nagbhushanam Nimmathota Arlappa A. Nirmala Ashok Kumar Pandey Ganta Venkata Prasad Mariya Amin Qurieshi Sirasanambatti Devarajulu Reddy Aby Robinson Seema Sahay Rochak Saxena Krithikaa Sekar Vijay K. Shukla Hari Bhan Singh Prashant Kumar Singh Pushpendra Singh Rajeev Singh Nivetha Srinivasan Dantuluri Sheethal Varma Ankit Viramgami Vimith Cheruvathoor Wilson Surabhi Yadav Kamran Zaman Aparup Das Rupinder Singh Dhaliwal Shanta Dutta Rajni Kant Anam Khan Kanwar Narain Somashekar Narasimhaiah Chandrasekaran Padmapriyadarshini Krishna Pandey Sanghamitra Pati Shripad A. Patil Hemalatha Rajkumar Tekumalla Ramarao Y.K. Sharma Shalini Singh Samiran Panda D. C. S. Reddy Balram Bhargava ICMR Serosurveillance Group

Background: Repeated cross-sectional serosurveys in the same geographic area establish trend of evolving pandemic. We present findings third round a national serosurvey to estimate seroprevalence SARS-CoV-2 infection among general population and health care workers India. Methods: conducted population-based between Dec 18, 2020 Jan 6, 2021 700 villages or wards from 70 districts 21 states across India, which were selected for first second serosurveys. enrolled each district, at least 400...

10.2139/ssrn.3810375 article EN SSRN Electronic Journal 2021-01-01

Recurrent Tuberculosis patients contribute to a significant proportion of TB burden in India. A nationwide survey was conducted during 2019–2021 across India among adults estimate the prevalence TB. total 322480 individuals were screened and 1402 having Of this, 381 (27.1%) had recurrent The crude (95% CI) 118 (107–131) per 100,000 population. median duration between episodes 24 months. drug resistant 11.3% 3.6% group new respectively. Higher observed elderly, males, malnourished, known...

10.1371/journal.pone.0294254 article EN cc-by PLoS ONE 2023-12-21

The arthropod-transmitted chikungunya virus has emerged as an epidemic menace that causes debilitating polyarthritis. With this life-threatening impact on humans, the possible treatment requires to cure viral infectivity. But, devoid of any vaccine against (CHIKV), there is a need develop novel chemotherapeutic strategy treat noxious infection. CHIKV carries highly compact P23pro-zbd structure possesses potential RNA-binding surface domains which extremely influences use RNA template during...

10.1002/jcb.29139 article EN Journal of Cellular Biochemistry 2019-07-16

The diagnosis of visceral leishmaniasis (VL) is one the foremost barriers in control this disease, as demonstration parasite by splenic/bone marrow aspiration relatively difficult and requires expertise laboratory support. aim present study was to find a noninvasive diagnostic approach using existing recombinant kinesine-39 (rK-39) immunochromatographic nitrocellulose strips test (ICT) with human sweat specimen for VL. investigation carried out on specimens (blood, sweat, urine) collected...

10.4269/ajtmh.17-0749 article EN American Journal of Tropical Medicine and Hygiene 2018-09-11
Manoj Murhekar Tarun Bhatnagar Jeromie Wesley Vivian Thangaraj V. Saravanakumar Muthusamy Santhosh Kumar and 93 more Sriram Selvaraju Kiran Rade C. P. Girish Kumar R. Sabarinathan Alka Turuk Smita Asthana Rakesh Balachandar Sampada Dipak Bangar Avi Kumar Bansal Vishal Chopra Dasarathi Das Alok Kumar Deb Kangjam Rekha Devi Vikas Dhikav Gaurav Raj Dwivedi Muhammad Salim Khan M. Sunil Kumar Avula Laxmaiah Major Madhukar Amarendra Mahapatra Chethana Rangaraju Jyotirmayee Turuk Rajiv Yadav Rushikesh Andhalkar K. Arunraj Dinesh Kumar Baradwaj Pravin Bharti Debdutta Bhattacharya Jyothi Bhat Ashrafjit S. Chahal Debjit Chakraborty Anshuman Chaudhury Hirawati Deval Sarang Dhatrak Ranjit Prasad D. Elantamilan Prathiksha Giridharan Inaamul Haq Ramesh Kumar Hudda Babu Jagjeevan Arshad Kalliath Srikanta Kanungo Nivethitha N. Krishnan Jaya Singh Kshatri Alok Kumar Niraj Kumar Vijay Kumar Gangeti Gandhi Jayanthi Naga Lakshmi Ganesh Mehta Nandan Kumar Mishra Anindya Mitra K. Nagbhushanam Nimmathota Arlappa A. Nirmala Ashok Kumar Pandey Ganta Venkata Prasad Mariya Amin Qurieshi Sirasanambatti Devarajulu Reddy Aby Robinson Seema Sahay Rochak Saxena Krithikaa Sekar Vijay K. Shukla Hari Bhan Singh Prashant Singh Pushpendra Singh Rajeev Singh Nivetha Srinivasan Dantuluri Sheethal Varma Ankit Viramgami Vimith Cheruvathoor Wilson Surabhi Yadav Suresh Yadav Kamran Zaman Amit Chakrabarti Aparup Das Rupinder Singh Dhaliwal Shanta Dutta Rajni Kant Anam Khan Kanwar Narain Somashekar Narasimhaiah Chandrasekaran Padmapriyadarshini Krishna Pandey Sanghamitra Pati Shripad A. Patil Hemalatha Rajkumar Tekumalla Ramarao Y.K. Sharma Shalini Singh Samiran Panda D. C. S. Reddy Balram Bhargava

Background: Repeated cross-sectional serosurveys in the same geographic area establish trend of evolving pandemic. We present findings third round a national serosurvey to estimate seroprevalence SARS-CoV-2 infection among general population and health care workers India. Methods: conducted population-based between Dec 18, 2020 Jan 6, 2021 700 villages or wards from 70 districts 21 states across India, which were selected for first second serosurveys. enrolled each district, at least 400...

10.2139/ssrn.3797589 article EN SSRN Electronic Journal 2021-01-01

Post-kala-azar dermal leishmaniasis (PKDL) is clinical outcome of visceral (VL) and thought to be the potential reservoir parasite. Miltefosine (MF) only oral drug existing for treatment post-kala-azar (PKDL). Increased miltefosine tolerance in isolates Leishmania donovani has been reported one major concerns PKDL. Here, we report a highly ulcerated PKDL case that was successfully cured after treatment.

10.1371/journal.pntd.0008052 article EN cc-by PLoS neglected tropical diseases 2020-03-23

Abstract Background Post–kala-azar dermal leishmaniasis (PKDL), a form of the disease, occurs in some visceral (VL) patients following treatment. The PKDL disease mechanism is not yet clearly understood. Here we have studied role fibroblasts VL and mechanism. Methods Dermal were grown from skin biopsy explants collected individual healthy controls. Fibroblasts third passage subjected to RNA sequencing analyze differentially expressed genes (DEGs). Significantly important further validated by...

10.1093/infdis/jiad049 article EN The Journal of Infectious Diseases 2023-02-23

A rapid and noninvasive rK39 diagnostic test (RDT) is the best most reliable tool for visceral leishmaniasis (VL) screening in field. However, splenic bone marrow aspiration remain two gold standard methods microscopic identification of Leishmania donovani (LD) bodies confirmatory diagnosis VL. Five patients with signs symptoms fever, loss appetite, weight, hepatomegaly, massive splenomegaly were found to be false positive RDT. These suspected have chronic myeloid leukemia (CML) because...

10.4269/ajtmh.20-0301 article EN American Journal of Tropical Medicine and Hygiene 2020-09-22

The occurrence of viral co-infection is always a challenging issue in pediatrics which indicates underestimation causal pathogens. A 6-year-old girl child from Patna had diagnosed rare case multi-viral February 2020. She was manifested with oblivion along high-grade fever, weakness, nasal bleed, headache, and body ache. altered sensorium mildly dilated pupils. Her three classical meningeal sign i.e. Kernig's sign, Brudzinski's nuchal rigidity were found positive. clinically investigated...

10.9734/ijtdh/2020/v41i1930384 article EN International Journal of TROPICAL DISEASE & Health 2020-12-11

There is a significant research gap in India due to incomplete investigation of seroprevalence co-infection with visceral leishmaniasis (VL), hepatitis B (HBV) and C (HCV). This study attempts fill this by providing an in-depth analysis the prevalence consequences these co-infections. The 32 VL patients revealed that 28 (8.88%) tested positive for HBV, 1 (0.317%) HCV 3 (0.95%) both HBV HCV. These results highlight how difficult it treat people two diseases at same time. An example makes...

10.9734/ijtdh/2024/v45i81578 article EN International Journal of TROPICAL DISEASE & Health 2024-08-19

The study was carried out on 1104 people of visceral leishmaniasis (VL) endemic region to detect the suitable marker in asymptomatic individuals that illustrate as a for conversion symptomatic VL subject. In this study, 46 (asymptomatic) with rK39 strip test positive without any previous sign and symptoms were later found symptomatic. Hematological immunological investigations illustrated lower hemoglobin (g/dl) increase interleukin-10 (IL-10) respectively from normal range which would be...

10.5455/jmas.52041 article EN cc-by-sa Journal of Medical and Allied Sciences 2019-01-01
Coming Soon ...